Teachers Advisors’s Ovid Therapeutics OVID Stock Holding History

Teachers Advisors’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$29K	Hold	16,253	–	–	﹤0.01%	2970
2018 Q4	$39K	Hold	16,253	–	–	﹤0.01%	2992
2018 Q3	$92K	Hold	16,253	–	–	﹤0.01%	3010
2018 Q2	$127K	Buy	+16,253	New	+$140K	﹤0.01%	3036
2018 Q1	–	Sell	-6,063	Closed	-$60K	–	3016
2017 Q4	$60K	Hold	6,063	–	–	﹤0.01%	3028
2017 Q3	$52K	Hold	6,063	–	–	﹤0.01%	3052
2017 Q2	$64K	Buy	+6,063	New	+$79.2K	﹤0.01%	3077

Other funds holding OVID

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Teachers Advisors's OVID Position: Q1 2019 in Review

Teachers Advisors held its Ovid Therapeutics (OVID) position steady in Q1 2019 at 16,253 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

Teachers Advisors first reported a position in OVID in Q2 2017 and has held it in 7 quarters since. The position peaked at $127K in Q2 2018. 50 funds tracked by Wall St. Rank hold OVID as of Q1 2019.

Teachers Advisors held 16,253 shares of Ovid Therapeutics worth $29K as of Q1 2019.
Teachers Advisors left its Ovid Therapeutics share count unchanged in Q1 2019.
Ovid Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2970 holding.
Teachers Advisors first reported a position in Ovid Therapeutics in Q2 2017 and has held it in 7 quarters since.
Teachers Advisors's Ovid Therapeutics position peaked at $127K in Q2 2018.
50 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.